Pathway and network analysis revealed two interaction hubs centered on the proteins FN1 and matrix metalloproteinase-9 (MMP9), which are upregulated in the SPEs of CRC patients and pathways that are involved in cytoskeletal organization and integrin signaling in tumor progression and metastasis by reprogramming tumor microenvironment [66]. The gene discussed is MMP9; the disease is neoplasm.